IRADIMED CORPORATION Announces Receipt of FDA Warning Letter
September 02, 2014 23:49 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Sept. 2, 2014 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (Nasdaq:IRMD) today announced that it received a warning letter from the U.S. Food and Drug Administration ("FDA") relating...
IRADIMED CORPORATION Announces Second Quarter 2014 Financial Results
August 12, 2014 07:20 ET
|
iRadimed Corporation
Reports revenue growth of 69% year-over-year
Reports non-GAAP diluted EPS of $0.13, a 79% increase over last year
Issues full year 2014 revenue guidance of $18.0 million to $18.2...
IRADIMED CORPORATION to Hold 2014 Second Quarter Financial Results Conference Call on August 12th
August 01, 2014 14:28 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Aug. 1, 2014 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (Nasdaq:IRMD) announced today that the Company will release its 2014 second quarter financial results before the market...